|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/14 | (2015.01) |
| A61K 35/14 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 38/17 | (2013.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Patento numeris | 2793913 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12859136.9 |
| Europos patento paraiškos padavimo data | 2012-11-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/AU2012/001345 |
| Data | 2012-11-02 |
| (87) | Numeris | WO 2013/090978 |
| Data | 2013-06-27 |
| (30) | Numeris | Data | Šalis |
| 2011905368 | 2011-12-21 | AU |
| (72) |
RAYNER, Craig , AU
|
| (73) |
CSL Limited ,
655 Elizabeth Street, Melbourne VIC 3000,
AU
|
| (54) | DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS |
| DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS |